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Abstract
In this commentary we highlight limitations with the way nonmedical use of prescription
medications has been measured in U.S. national studies. We also offer an alternative way of
conceptualizing the nonmedical use of prescription medications for future study.
The term nonmedical use of prescription medications is often
used by researchers to describe the misuse of controlled
medications by people who misuse someone else's pre-
scription medication(s) or patients who misuse their own
prescription medications (without a physician's knowl-
edge). Nonmedical users may abuse their own medicines
via non-oral routes to get high (e.g., snorting) while other
nonmedical users may be given pills (for instance, from a
family member) to self-treat a medical condition. Those
with their own prescriptions may divert their medications
to nonmedical users, while some nonmedical users may
engage in doctor shopping in order to obtain a "legal" pre-
scription. Thus, the term nonmedical use of prescription med-
ications has come to characterize a heterogeneous group of
motivations and related behaviors.
Despite the recent attention devoted to this form of drug
abuse, relatively little is known about the different behav-
iors associated with the nonmedical use of prescription
medications. Neither misuse of one's own medications
nor motivations to engage in nonmedical use are ade-
quately assessed in many of the existing epidemiologic
studies that focus on substance abuse, including the
National Survey on Drug Use and Health (NSDUH) [1],
Monitoring the Future (MTF) [2], and the National Epidemi-
ologic Survey on Alcohol and Related Conditions (NESARC)
[3]. While these large studies have contributed to our ini-
tial understanding of nonmedical use, it is equally true
that they have failed to advance our understanding of the
diversity of behaviors associated with the nonmedical use
of prescription medications.
Each of the three national studies relies on somewhat dif-
ferent survey questions to assess the nonmedical use of
prescription medications – and each has limitations. Mon-
itoring the Future uses the most straightforward question,
stipulating that the drug was taken without a doctor's order,
although whether respondents are using their own pre-
scription medications or using diverted medications is not
determinable. The NSDUH and the NESARC both use one
complex question, stipulating that the drug was not pre-
scribed and then each adding, "was taken for the experience or
feeling it caused" (NSDUH) or "to feel more alert, to relax or
quiet nerves, to feel better, to enjoy themselves, or to get high or
just to see how they would work" (NESARC). The NESARC
question also stipulates an increase in amount, frequency,
and/or longer duration than prescribed. A complex ques-
tion means that respondents may answer affirmatively to
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tions, making it impossible for researchers to determine
exactly which behaviors were endorsed.
Fifteen years ago, Hubbard and colleagues [4] critiqued
the way in which "nonmedical use of prescription drugs"
was often measured. In their paper, they noted that the
NSDUH question used to measure nonmedical use was
problematic because respondents were expected to recall
multiple sets of information in one question. In the cur-
rent NSDUH, respondents must decide: a) whether they
used a controlled drug without a prescription, or b)
whether they used a controlled medication for the experi-
ence or feeling it caused, or c) whether they used the con-
trolled medication for some other reason. The NESARC
question builds on the NSDUH but then adds even more
information to the question. That is, respondents must
decide if the controlled medication was: a) taken in
greater amounts, or b) more often, or c) longer than pre-
scribed.
There are other problems with the questions about non-
medical use in the national surveys. In one nonmedical
use question, the NSDUH combines illicitly produced or
"street" versions of drugs with controlled prescription
medications. For instance, prescription stimulants such as
methamphetamine, Desoxyn®, "uppers," "speed," Ritalin®
or methylphenidate are all combined within one ques-
tion. Thus, researchers using the NSDUH stimulant data
are forced to use the term "prescription-type" medications
when writing about the nonmedical use of stimulant
medications. Monitoring the Future and the NESARC have
similar problems. In the MTF, the same question asks
about "street" amphetamines (e.g., crystal methampheta-
mine) and prescription medications (e.g. Ritalin®),
although some versions of the MTF specifically ask about
individual prescription amphetamines. This forces
researchers using the MTF data to use the term "prescrip-
tion-type" medications when providing prevalence esti-
mates for nonmedical use of amphetamines because street
amphetamines are included in the question. The NESARC
(Wave 2) has a somewhat different problem. It combines
opioid analgesics with Cox-2 inhibitors in a single ques-
tion about the nonmedical use of prescription pain med-
ications. Thus, a respondent may be categorized as a
nonmedical user of prescription pain medications BUT
may never have used a prescription opioid (either medi-
cally or nonmedically). A Cox-2 inhibitor has no abuse
potential and is not controlled (scheduled) medication,
while all prescription opioid medications have abuse lia-
bility and are controlled. In the NESARC (Wave 2), these
medications are "lumped" together into one question.
Given the limitations with the nonmedical questions in
the national studies, it is virtually impossible to verify sub-
types of nonmedical users from these studies, subtypes
that have only been described in smaller, exploratory
studies [5-8]. In particular, the national studies make it
Table 1: Subtypes of the nonmedical use of controlled drug classes
Person does not possess a legal prescription Person does possess a legal prescription
MOTIVATED BY:
• Desire to get high; create an altered state or 
experimentation.
Type 1:
A problem behavior that is motivated by 
the desire to experiment, to get high, or to 
create an altered state with someone 
else's medication.
Type 3:
A problem behavior that is 
motivated by the desire to 
experiment, to get high, or to 
create an altered state with one's 
own medication.
RELATED BEHAVIORS:
• Use in "recreational" settings
• Use for reasons other than self-treatment
• Use of scheduled medication with alcohol or other 
drugs simultaneously (co-ingestion)
• May use alternate route of administration 
(IV, snorting)
MOTIVATED BY:
• Desire to alleviate symptoms of an actual or 
perceived health condition; uses medication for its 
pharmacological purpose (e.g., uses sleeping 
medication for insomnia) but does NOT involve 
mixing with alcohol or other drugs or non-
therapeutic routes of administration.
Type 2:
A problem behavior motivated by the 
desire to self-treat with someone else's 
medication.
Type 4:
A problem behavior motivated by 
the desire to self-treat with one's 
own medication but without the 
approval of the prescribing 
professional.
RELATED BEHAVIORS:
• May include an increase in the recommended 
frequency, dose, or durationPage 2 of 3
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very difficult to determine whether the nonmedical user
was: using his own controlled medication; using someone
else's diverted medication; only using a controlled medi-
cation (and not a street drug), or using a controlled med-
ication for the experience it caused or for some other
reason.
The measurement limitations related to the "nonmedical
use of prescription medications" obscures the complexity
of this behavior and its related motives. It is for this reason
that we propose that future researchers craft questions that
disaggregate nonmedical use from motive and possession
(see Table 1), thereby producing data that could better
help researchers study the health consequences of the
nonmedical use of controlled medications and assist pre-
vention and treatment experts to craft more targeted mes-
sages.
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